Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Low-glycemic Index Diet and ADHD. (GI-ADHD)

13. november 2026 oppdatert av: Shimaa Shaker Attia Gafar, Kafrelsheikh University

Effect of Low Glycemic Index Diet in Attention Deficit Hyperactivity Disorder in Children.

This randomized controlled trial will evaluate the effect of a low glycemic index (GI) diet on symptoms of attention deficit hyperactivity disorder (ADHD) in children and adolescents. A total of 128 participants aged 6 to ≤18 years, diagnosed with ADHD according to the Conners Parent Rating Scale-48 (CPRS-48), will be recruited from the pediatric neurology outpatient clinic at Kafrelsheikh University Hospital and randomly assigned in equal numbers (64 per group) to one of two arms. The intervention group will receive a structured low-GI diet (whole grains, legumes, low-GI non-starchy vegetables and fruits, and lean proteins, with refined flour, white rice, and sugary snacks limited) delivered through the Clinical Nutrition Unit, supported by a low-GI pyramid teaching tool, regular dietary counseling, and weekly dietitian review of 3-day food records to monitor adherence. The control group will continue a normal diet. ADHD symptoms will be assessed with the Conners 48 scale at baseline, 1 month, and 6 months. Children with other neurological conditions, autism spectrum disorder, intellectual disability, severe psychiatric conditions, chronic illnesses, diabetes, celiac disease, or food allergies requiring dietary restrictions will be excluded. Written informed consent will be obtained from parents or guardians, and the study has ethics committee approval (REC-KFSIRB200, Kafrelsheikh University).

Suggested additional fields

Primary outcome: Change in Conners 48 score from baseline to 1 and 6 months Study type / design: Interventional; parallel-group randomized controlled trial; prospective Intervention type: Dietary supplement/behavioral (dietary intervention)

Studieoversikt

Status

Har ikke rekruttert ennå

Intervensjon / Behandling

Detaljert beskrivelse

Background and rationale

Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder of childhood and adolescence, characterized by persistent inattention, hyperactivity, and impulsivity. It affects an estimated 3.4% of children and youth worldwide and places a considerable burden on the individual, family, and society, with consequences that include educational difficulties, strained peer relationships, accidental injuries, and substance misuse. Medication and behavioral therapy are the most effective established treatments, but diet is a modifiable environmental factor that has been explored as a complementary approach. The glycemic index (GI) ranks foods by their effect on blood glucose (low GI: under 55; medium: 55 to 70; high: above 70). It has been proposed that a low-GI diet, by providing a steady supply of glucose to the brain together with nutrients needed for neurotransmitter production, may stabilize blood glucose, improve cognitive performance, and reduce behavioral swings. No previous studies were identified that specifically examine the effect of a low-GI diet on ADHD in children, and clinical research is needed to confirm whether it is effective.

Objective

To explore the effect of a low-GI diet on ADHD symptoms in children and adolescents.

Study design

This is a prospective, interventional, parallel-group randomized controlled trial with two arms. The study will be conducted at the pediatric neurology outpatient clinic of Kafrelsheikh University Hospital, and the dietary intervention will be delivered at the outpatient clinic of the Clinical Nutrition Unit of the same hospital.

Sample size

No prior data were available, so a moderate effect size (Cohen's d = 0.5) was assumed. Using G*Power 3.1.9.7 for a two-tailed independent-samples t-test, with 80% power and a 5% significance level, the required sample size was 128 participants (64 per group).

Participants

128 children and adolescents aged 6 to 18 years with ADHD diagnosed using the Conners Parent Rating Scale-48 (CPRS-48).

Inclusion criteria:

Diagnosis of ADHD according to the Conners 48 scale Age 6 to 18 years Not currently on a special diet Caregivers willing to adhere to the dietary intervention

Exclusion criteria:

Other neurological antecedents (such as epilepsy or febrile seizures) Comorbid autism spectrum disorder, intellectual disability, or severe psychiatric conditions Chronic illness (hepatic, renal, or cardiac dysfunction), diabetes, celiac disease, or food allergies requiring dietary restrictions Syndromic children

Interventions

Group I (intervention, n = 64): Participants will follow a structured low-GI diet based on a Low-GI Pyramid used as a teaching tool. The diet emphasizes whole grains (e.g., oats, barley), legumes (e.g., lentils, beans), non-starchy vegetables and fruits with a GI below 55, and lean proteins, while limiting high-GI foods such as refined flour, white rice, and sugary snacks. Compliance will be monitored through weekly dietitian review of 3-day food records. Regular dietary counseling sessions with parents will reinforce adherence and resolve problems as they arise.

Group II (control, n = 64): Participants will continue their normal diet.

Assessments

All participants will undergo:

Complete history taking (presenting symptoms, onset, duration, impact across settings, family, developmental, medical, and school history) Complete systemic clinical examination (heart, chest, abdomen, and general examination) Comprehensive nutritional assessment, including dietary history, anthropometric measurements (weight, height, BMI, and their Z-scores), and a nutrition-focused physical examination to rule out signs of micronutrient deficiency ADHD symptom assessment using the Conners Parent Rating Scale-48 at baseline, 1 month, and 6 months

Outcome measures

The primary outcome is the change in Conners 48 score from baseline to 1 month and 6 months, compared between the low-GI diet group and the control group. Dietary adherence, based on 3-day food records, is monitored throughout.

Statistical analysis

Data will be analyzed with statistical software using appropriate methods and presented in tables and graphs.

Ethics

The study has been approved by the Scientific Research Ethics Committee, Kafrelsheikh University (REC-KFSIRB200). Written informed consent will be obtained from the parents or guardians of each child before data collection begins.

Studietype

Intervensjonell

Registrering (Antatt)

128

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

6 år til 18 år (Barn, Voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Diagnosis of ADHD according to the Conners Parent Rating Scale-48 (CPRS-48) Age 6 to 18 years Not currently on a special diet Caregivers willing to adhere to the dietary intervention

Exclusion Criteria:

  • Other neurological antecedents (such as epilepsy or febrile seizures) Comorbid autism spectrum disorder, intellectual disability, or severe psychiatric conditions Chronic illness (hepatic, renal, or cardiac dysfunction), diabetes, celiac disease, or food allergies requiring dietary restrictions Syndromic children

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Low glycemic index diet.

Children and adolescents with ADHD (n = 64) follow a structured low-GI diet based on a Low-GI Pyramid teaching tool: whole grains, legumes, low-GI non-starchy vegetables and fruits (GI below 55), and lean proteins, limiting refined flour, white rice, and sugary snacks. Regular dietary counseling sessions and weekly dietitian review of 3-day food records support adherence.

Structured low-GI diet with dietary counseling and weekly review of 3-day food records.

Linked arm: Arm 1

Ingen inngripen: Normal diet (control).

Children and adolescents with ADHD (n = 64) continue their usual diet.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in ADHD symptom severity.
Tidsramme: Baseline, 1 month, and 6 months.

Change in total score on the Conners Parent Rating Scale-48 (CPRS-48), completed by parents or caregivers. The change from baseline is compared between the low glycemic index diet group and the normal diet group. Higher scores indicate more severe symptoms.

Baseline, 1 month, and 6 months.

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

30. november 2026

Primær fullføring (Antatt)

30. juni 2027

Studiet fullført (Antatt)

31. juli 2027

Datoer for studieregistrering

Først innsendt

13. november 2026

Først innsendt som oppfylte QC-kriteriene

13. november 2026

Først lagt ut (Faktiske)

19. november 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

19. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

13. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere